0001140361-11-029071.txt : 20110520 0001140361-11-029071.hdr.sgml : 20110520 20110520161112 ACCESSION NUMBER: 0001140361-11-029071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110518 FILED AS OF DATE: 20110520 DATE AS OF CHANGE: 20110520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SABEL IVAN R CENTRAL INDEX KEY: 0001217563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 11861742 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0303 4 2011-05-18 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001217563 SABEL IVAN R 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 1 0 0 0 Common Stock 2011-05-18 4 A 0 6500 0 A 169194 D Common Stock 2011-05-18 4 A 0 1283 25.72 A 170477 D Common Stock 1100 I IRA Common Stock 1100 I Spouse's IRA Option to Buy 14.23 2003-05-30 2012-05-29 Common Stock 100000 100000 D Option to Buy 13.80 2004-08-01 2013-07-31 Common Stock 90000 90000 D Consists of restricted stock units granted under the Company's 2010 Omnibus Incentive Plan (the "Plan"), which vest to the extent of one-third on May 18, 2012 and cumulatively vest to the extent of one-third each year thereafter, subject to certain provisions of the Plan. Consists of restricted stock units which the Reporting Person elected to receive in lieu of the annual director fee payable to the Reporting Person. This option was fully vested on June 23, 2005. /s/ Teri L. Champ, Attorney-in-Fact for Ivan R. Sabel 2011-05-20